Trial Profile
Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Novartis
- 13 Oct 2009 Actual patient number (40) added as reported by ClinicalTrials.gov.
- 13 Oct 2009 Actual end date (Feb 2007) added as reported by ClinicalTrials.gov.
- 13 Oct 2009 Status changed from discontinued to completed as reported by ClinicalTrials.gov.